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Abstract
TWO METHODS TO DETECT CLONAL POPULATIONS OF HUMAN CELLS
IN SITU. Philip Hall, Jonathan Murphy, and Jeffrey Sklar, Department of Pathology,
Yale University, School of Medicine, New Haven, CT.
A molecular assay to detect clonal populations of human cells in situ would be
potentially valuable for both investigational and diagnostic purposes. Two such
methods are proposed, both utilizing fluorescence in situ hybridization (FISH). The
first relies upon random monoallelic expression of genes (so-called allelic exclusion),
in which a subset of human genes are normally expressed at a single allele in a fixed
fraction of cells within a tissue, independent of the parental origin of the allele. It is
hypothesized that application of FISH to assess the allelic expression patterns among
one or more of these genes should be able to distinguish a monoclonal population of
cells from a polyclonal one. The second method, specific for T-cells, relies upon
VDJ segmental recombination at the T-cell receptor beta locus. With this method,
our hypothesis is that analysis by FISH of the configuration of rearranged VDJ
segments should be able to distinguish a monoclonal population of T cells from a
polyclonal population. Both proposed assays were tested on benign tonsil and
thymus tissue as well as on monoclonal cell pellets produced from neoplastic cell
lines. In those analyses that could be completed, attempts to assess the expression
pattern either of genes subject to random allelic exclusion or the determination of
VDJ segmental recombination failed to distinguish monoclonality from polyclonality.
Although unsuccessful, the failure of these attempts was due to technical limitations
and not to fundamental problems with the underlying hypotheses.
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4
Introduction
The ability to determine whether a population of human cells is clonal, its
lineage traceable to the division of a single cell, has been valuable for various types of
basic biologic studies and for certain diagnostic applications. An important area for
which considerations of clonality are relevant is neoplasia and cancer. Most, if not all
neoplasms arise from the clonal proliferation of cells derived from a single
transformed precursor cell (1-6). Moreover, the identification of multiple different
types of preneoplastic or premalignant lesions has motivated the investigation of their
clonality, especially in connection to the risk of potential transformation to true
neoplasia. Indeed, several molecular methods now in widespread use for the
diagnosis and detection of some human cancers rely upon the identification of a
monoclonal population of cells (4, 7-9). These methods have all involved extraction
of nucleic acids from cells that have been removed from tissues and are not broadly
applicable to all cell types. In this thesis, we propose two methods of expanding the
applicability of assays for monoclonality, notably using in situ techniques that
preserve cell and tissue morphology, with a discussion of initial experience with these
methods.
The difficulty of creating an assay for clonality derives from the fact that
neoplastic cells share most of the same genetic makeup as non-neoplastic cells and
display many of the same proteins. For those specific differences that occur,
distinguishing neoplastic from normal, polyclonal cells by their genetic or protein
composition alone requires prior knowledge of, or an extensive, often expensive
search for how the two populations differ (1, 6, 10-11). In this manner, identifying
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one or more genetic variants--such as a specific point mutation, as occurs frequently
in neoplasia; a DNA deletion, as is associated with tumor suppressor genes; or a
chromosomal translocation, as is found in several hematologic malignancies and
sarcomas--has been beneficial not only for advancing our understanding of
carcinogenesis but also for improving our ability to diagnose malignancy (6, 11).
Unfortunately, for most cancers, a defining genetic variation either is not known, is
present in only a fraction of cases of a given cancer, or is not a convenient marker for
technical reasons (e.g., mutations that might occur anywhere over large regions of
DNA within an oncogene). On these grounds, a generic, broadly applicable test for
clonality would be of great diagnostic utility.
In the absence of a broadly applicable, objective test for clonality, current
methods of diagnosing cancer continue to rely on the evaluation of morphologic and
histopathologic features, which are subject to interobserver variability (12, 13).
Nevertheless, because of the many decades of experience with the histopathology of
tumors, much information has been accumulated about the histopathologic
characteristics of neoplasms, and morphology-based diagnostic criteria have been
established. A reliable and convenient method of detecting clonality would be
valuable to both researchers and diagnosticians, particularly if clonality could be
assessed in situ and directly correlated with morphology.
There have been several proposed assays to determine the clonality of a
population of human cells, but each has been hampered by limitations related to
specific tissues or to technical problems that restrict its use. Very few offer the
potential for in situ analysis. The assays that can be applied to detect monoclonality
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in more than one or a few specific tumor types have relied upon the determination of
one of a small number of genetic events that are known to occur randomly during the
differentiation of certain somatic cells. The guiding principle of such assays is that
certain genetic or epigenetic events, whether dichotomous, as in the choice of a kappa
or lambda light chain immunoglobulin gene for expression in B lymphocytes; or
polychotomous, as in T-cell receptor or immunoglobulin gene rearrangement
patterns, occur randomly in a polyclonal population of human cells; i.e., each cell in
the population is (or is descended from) a cell in which the genetic or epigenetic
event has occurred and has resulted in a fixed change (kappa expression vs. lambda,
or a particular VDJ rearrangement) (4, 6-7, 9, 14-31). A monoclonal population,
however, will display a decidedly, or statistically, non-random pattern, if the genetic
or epigenetic event occurred prior to the clonal expansion of that particular cell
population. As an example, the ratio of B lymphocytes making kappa to B
lymphocytes making lambda light chains, within a given population of non-neoplastic
cells, should fall within a statistically predictable range centered around 2:1.
Deviation from that range is evidence of the presence of a clonal population (6).
Similarly, the configuration of rearranged V, D, and J segments that have been joined
together in the immunoglobulin heavy chain loci of genomic DNA (as well as the
precise sequence of DNA at the junction of these segments and the length of that
sequence) differs among different mature B lymphocytes. Gel electrophoresis of the
products generated from the cellular DNA of a polyclonal population of B
lymphocytes by the polymerase chain reaction (PCR) using primers that flank the
VDJ junctions within the immunoglobulin heavy chain locus results in a smear of
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similarly sized but diverse bands that differ in their precise lengths. In contrast, the
finding of a discrete band by gel electrophoresis is indicative of the presence of a
monoclonal population, i.e., that a significant fraction of the cells have an identical
VDJ rearrangement, implying that those cells are all derived from a single precursor
cell in which that particular VDJ rearrangement occurred (4, 8-10, 30, 32). Both of
these examples, where specific, non-random events distinguish monoclonal from
polyclonal cell populations, in which comparable events are random, have been used
by clinicians to aid in the diagnosis of malignancy, notably lymphocytic cancers (2, 4,
7-9, 30, 33, 34). As illustrated by these examples, PCR, along with flow cytometry
and immunohistochemistry, remain the diagnostic tools of choice for many
lymphoproliferative disorders (35). However, these examples are limited to
lymphocytes, the only cells known to undergo somatic recombination in a specific
genetic locus during normal maturation and differentiation or to produce kappa or
lambda light chains.
An assay for clonality must target a genetic or epigenetic event that occurs in
the type of cell from which the neoplasm (or clone) arises. Thus, the most useful
genetic/epigenetic event would be one that occurs in all somatic cells. An assay
widely used in basic biologic studies has focused on X-chromosome inactivation, a
random dichotomous event that occurs in female somatic cells during early
embryologic development, whereby in each cell, either the maternally- or paternallyderived X-chromosome is inactivated, with stable transmission of the inactivated state
to the same X chromosome in all of that cell’s progeny (1, 6, 36). Assays that can
distinguish whether the active X-chromosome in a female somatic cell is paternally-
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or maternally-derived allow for clonal analysis of a population of human cells.
Evidence for preponderance of inactivation of one or the other X-chromosome
homologs is consistent with a monoclonal population of cells. However, such
assessments depend in part on the characteristics of the background cell population
and the ratio between activation of the two X-chromosomes in the particular tissue in
which a population of cells is being analyzed, since skewing from the theoretical 1:1
ratio is sometimes observed in normal tissues. Initial attempts to distinguish the
active X-chromosome relied on the analysis of gene products in female individuals
heterozygous for a gene on the X-chromosome, commonly glucose-6-phosphate
dehydrogenase (1, 3). While successful, these analyses were limited by the relative
rarity of individuals heterozygous for those particular polymorphisms (3). Later
analyses were based on the fact that DNA of the inactive X-chromosome is
hypermethylated relative to the active X-chromosome. To distinguish the active from
inactive X-chromosome DNA, the DNA extracted from the tissue sample was cleaved
using methylation-sensitive endonucleases, followed by Southern blot hybridization,
or, alternatively, DNA of a gene on the X-chromosome, typically the PGK or
androgen receptor gene, was amplified using PCR, followed by analysis of the
products by gel electrophoresis. In either of these strategies, X-chromosome loci
were selected for analysis based on highly prevalent polymorphisms in DNA
sequence that could be detected either by restriction fragment length polymorphism
(RFLP) in Southern blot analysis or differently-sized PCR products (3, 5, 10, 37).
Such polymorphism analysis enabled distinction of the two X-chromosomes within
female tissues and permitted analysis of a larger percentage of females than were
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heterozygous for G6PD. However, even using these methods, it was still possible to
accomplish analysis in only a fraction of cases. For example, in one study, only
thirteen of the fifteen tissue samples could be analyzed, either due to skewing in the
normal surrounding tissues or, less frequently, to lack of heterozygosity in the locus
used for analysis (3).
In addition to other technical limitations, the above strategies for analysis of
clonality have been limited either to lymphocytes or to female somatic cells. Other
strategies have been employed in particular settings. For example, variations in the
stucture of Epstein-Barr virus (EBV) episomal DNA has been used as a clonal
marker. Each cell infected with EBV has multiple identical circular episomes of viral
DNA, formed by covalent ligation of the two ends of the double-stranded, linear
genome upon cellular infection. Both ends of the linear genome are composed of the
same tandem repeat sequences, about 500 basepairs in length, and the episomal form
of the EBV genome in latently infected cells is generated by homologous
recombination between the tandem repeats leaving variable numbers of such repeats
in the episomal circles. The number of included repeats is stable and is passed on by
precursor cells to their progeny without variation (6, 38). Analyzing the length of the
region containing the repeats by Southern blot has helped identify clonality within
several tumors, including nasopharyngeal carcinoma and Hodgkin’s disease, but is
obviously limited to EBV-infected cells (6, 38, 39). Other techniques have analyzed
sites of integration into host cell DNA by Hepatitis B viral DNA, as a unique marker
of an infected cell and its progeny. As with EBV, this marker is limited to only
specific situations, such as hepatocellular carcinoma (6, 40).
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The clonality assays already described have increased our understanding of
carcinogenesis and enabled clonal analysis of multiple tumor types and preneoplastic
processes. However, these assays have generally not been used routinely for
diagnosis because of the difficulties or complexities of the technique or the lack of
broad applicability to many tumor types (37, 41, 42). An ideal assay, then, would
need to target a genetic event that occurs randomly within a given population of cells,
one that occurs in multiple or most cell types and populations, one that produces
some heritable, cellular change that is not affected by growth conditions or by
neoplastic transformation, and one that can be easily assessed. Random monoallelic
gene expression, also referred to as allelic exclusion, may provide exactly such an
event, especially in light of the multiple recent advances in our understanding both of
the process itself and of its prevalence within cells.
Monoallelic expression occurs when one of two alleles for a specific gene is
activate and the other is inactive, such that only one of the two alleles is transcribed.
This situation may arise through the random activation of one allele while the other
allele remains inactive, or, conversely, through the random inactivation of one allele
of a gene in which both alleles are initially active. On a chromosome-wide basis, a
similar process gives rise to random X-chromosome inactivation in female somatic
cells. So-called imprinting of autosomal genes also involves inactivation of only one
allele in somatic cells, but differs fundamentally from random monoallelic expression
because either the paternally- or maternally-inherited copy of an imprinted gene is
consistently inactivated (36, 43-45). Imprinted genes have been implicated in several
inherited human diseases, the best known being Prader-Willi and Angelman

11
Syndrome, which are both due to deletion of the same chromosomal region (15q1113) but differ phenotypically depending upon the parental origin of the chromosome
that suffers the deletion (43, 44, 46).
A third type of monoallelic expression involves random transcriptional
inactivation of a single allele in cells in which both alleles are initially active; in this
type of monoallelic expression, the choice of which allele is expressed is independent
of its parental origin (47-52). In fact, it seems that random monoallelic expression of
a given gene often occurs in only a minority of the cells within a tissue in which that
gene is active, but it appears to be a stable percentage (50). In 1994, Chess et al.
described random monoallelic expression of olfactory receptor genes in sensory
neurons, and in 2007, Gimelbrant et al. analyzed 4,000 somatic human genes in
clonal cell lines and identified 300 as demonstrating random monoallelic expression
(48, 50). The expression patterns indicated that monoallelic expression was
frequently present in a consistent minority of cells regardless of the specific tissue
from which the cells were derived.
Compared to the markers for clonality so far described, random monoallelic
expression has several theoretical advantages. It occurs in genes on multiple
autosomal chromosomes, making it usable in both male and female cells. For several
genes identified in the Gimelbrant study, evidence was provided that random
monoallelic expression was present in multiple tissue types in a measurable and
consistent percentage of cells within each tissue type, but not in all cells. Finally,
random monoallelic gene expression is observed in a significant minority of
expressed genes, each of which could be a promising target for a clonality assay
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depending upon the particular tissue and the extent to which that gene is expressed in
a monoallelic fashion within that tissue (i.e., the fraction of cells that exhibit
monoallelic expression).
The difficulty in creating an assay for clonality arises in creating a molecular
technique to identify the pattern of monoallelic expression within a population of
cells. The necessary and important assumption, to be confirmed or rejected in this
and future studies, is that the pattern of random monoallelic expression is passed from
progenitor cells to their progeny in a stable fashion. However, as stated above, Xchromosome inactivation is the biologic process most analogous to random
monoallelic gene expression and the stability of inactivation in that process is well
known. Given the success of assays targeting X-chromosome inactivation, random
allelic inactivation would seem a promising target for investigation for this
experiment. Although it would be possible to use a similar technique to that used in
X-chromosome inactivation, namely the analysis of polymorphisms within a gene
subject to random monoallelic expression, the limited association of suitable and
predictable polymorphisms within appropriate genes greatly complicates this
approach. But even more importantly, random allelic inactivation occurs in only a
percentage of cells, instead of in every cell as with X-chromosome inactivation.
Upon initial consideration, this observation presents a difficult challenge for
distinguishing a monoclonal population of cells from a polyclonal population based
on patterns of allelic expression, at least if an approach similar to that used for
assessing X-chromosome inactivation were employed. However, this feature of
monoallelic gene expression in subtotal fractions of cell populations within tissues
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actually offers a special opportunity for its use as a marker for in situ detection of
clonality.
Despite the advantages of in situ assays for the determination of
monoclonality in preneoplastic or neoplastic tissues in histologic sections, very few
such assays currently exist. The one in situ clonality assay widely used at present in
clinical settings has employed antibody staining for kappa and lambda
immunoglobulin light chains (6). Besides being limited to B cells, this method has
various disadvantages, principally problems involving its application to formalinfixed, paraffin-embedded tissues - the standard material from which histologic
sections are prepared. In situ hybridization for kappa and lambda immunoglobulin
light chain mRNA has also been utilized (53), but this approach is generally
considered too difficult for routine clinical use. In 2001, Nuovo et al. described the
use of reverse transcriptase in situ PCR to detect T-cell-receptor beta rearrangements
in T cell populations, which enabled them to distinguish clonal T cell populations in
lymphomas from polyclonal populations in reactive lymph nodes (54). However, this
method has significant drawbacks that hinder its clinical adoption, notably its
requirement for multiple tissue sections and sequential experimental repetitions to
distinguish among different V segments using the twenty-five forward primers
necessary to detect the uniquely expressed TCR-beta rearrangements. Furthermore,
in situ PCR is a very problematic technique that is not in general use because of
limited reproducibility.
On the other hand, in situ genetic examination has been greatly augmented by
advances in fluorescence in situ hybridization (FISH) (27, 55-57). FISH has been

14
widely adopted clinically in the diagnosis and characterization of many malignancies,
largely based upon its ability to detect genetic translocations, deletions, and other
chromosomal abnormalities (56, 58). All of these applications involve hybridization
to DNA targets. Additionally, a simple modification of DNA FISH--RNA FISH,
which targets RNA sequences--has enabled the study of gene expression by
identifying sites of RNA transcription at the cellular level (43, 57, 59-66).
Importantly, the technology can be used with formalin-fixed, paraffin-embedded
tissue, rendering it promising for pathologic research and clinical diagnosis (67).

In

the Gimelbrant study, the use of RNA FISH was coupled with DNA FISH to confirm
monoallelic or biallelic expression of two sample genes, death-associated protein
kinase 1 (DAPK1) and early B cell factor (EBF), in peripheral blood monocytes
(PBMCs) and clonal lymphoblast lines (50). In this study, 36% and 38% of PBMCs
showed monoallelic expression for the two genes, respectively, and in the clonal
lymphoblast lines known to display monoallelic expression of one or both genes, 97%
and 98% showed monoallelic expression with FISH. However, only 77% and 78% of
cells from clonal lymphoblast lines known to have biallelic expression of the two
genes displayed biallelic expression with FISH. The reasons for this seem likely to
be technical.
Despite the reduced sensitivity of combined RNA and DNA FISH for
detecting biallelic expression, use of these methods still seems to offer a promising
method for clonality analysis. If RNA and DNA FISH were used to assay whether
one or both alleles for a given gene are expressed in a collection of human cells, the
ratio of monoallelic to biallelic expression should fall within a statistically predictable
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ratio, depending upon the gene chosen for analysis, the tissue in question, and the
sensitivity of the assay. To increase the sensitivity of the assay, it should also be
possible to investigate the expression patterns of multiple genes simultaneously with
probes tagged with multiple fluorophors to distinguish the different genes. This is the
strategy we chose for our studies.
We began by selecting two genes for analysis, based upon their expression
and prevalence of random monoallelic inactivation in many tissues. These genes
were in fact the same two used for FISH analysis in the Gimelbrant study: DAPK1, on
chromosome 9q34, and early B cell factor (EBF), on chromosome 5q34 (50). We
then designed a fluorescent probe for hybridization to intronic sequences of these
genes. The same probe was selected for both RNA and DNA FISH, with the method
of hybridization distinguishing between the RNA and DNA targets. For each gene,
DNA FISH serves as an internal control, as it should identify two alleles in each cell.
RNA FISH tests whether transcription is monoallelic or biallelic, based on the
presence or absence of a nascent, unspliced mRNA (59, 60, 65). The use of an
intronic probe assures that only nascent mRNA will be visualized, since mature
mRNA lacks the introns to which the probe is designed to hybridize. Because
splicing of exons occurs soon after transcription, or perhaps even co-transcriptionally,
nascent, precursor mRNA is localized near or at the site of transcription, close to the
gene encoding that mRNA.
While the published data forming the rationale and methodologic bases for
these studies for in situ assessment of clonality seemed fairly strong, we also decided
to pursue a parallel, more limited but still potentially useful approach to the in situ
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assessment of clonality for clinical purposes. This approach also involved FISH and
was directed at assessment of the clonality of T cells. As described above, Nuovo et
al. used RT in situ PCR for their assay because FISH was thought to be too
insensitive at the time to identify the short regions of DNA involved in TCR beta
recombination and because of the need to use multiple probes on several tissue
sections to distinguish among the myriad possible combinations of variable (V),
diversity (D), or joining (J) segments (54). However, we decided to attempt an
approach markedly different from that of Nuovo, et al. by utilizing FISH directed at a
specific region in the TCR beta gene and a statistical feature of TCR beta gene
rearrangement that characterizes the TCR beta gene in normal T lymphocytes.
In a review of T cell development published in 1992, Malissen et al.
discussed the frequency of various configurations of TCR beta gene rearrangements
among T cells. Within developing T cells, both alleles undergo D-J joining, but
whether or not only one or both alleles undergo subsequent V-DJ joining depends
upon the outcome of first V-DJ rearrangement with respect to production of a
functional protein product. If rearrangement in that first allele is successful, the
second allele does not undergo rearrangement (68). Great diversity in the sequence
of DNA across the VDJ junction occurs among fully rearranged alleles due to the
combined effects of exonucleolytic digestion removing varying numbers of basepairs
at the ends of recombining segments plus the addition of variable numbers of random
basepairs at the ends of the segments by the enzyme terminal transferase prior to
ligation of V, D, and J segments. Non-functional VDJ rearrangements are relatively
common, since two-thirds of the sequences generated at the VDJ junctions will be out
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of frame in the J and C (constant region) coding sequences. Malissen et al. predicted
accordingly a two-thirds failure rate for the first allelic rearrangement and a twothirds failure rate for the second allelic rearrangement. As a viable T cell needs at
least one successful V-DJ rearrangement of the TCR beta allele, the ratio of cells with
one rearranged locus and one non-rearranged locus to those with two rearranged loci
should be about 3:2, as summarized in Figure 4 of their paper. In an analysis of ten T
cell clones, they found a ratio of 5:5, with one clone interestingly possessing two
successful V-DJ recombinations.
Although their experiment was done in murine T cells and we could find no
analogous analysis of human T cells, we thought that while the ratio might be
somewhat different in human T cells, the principle should still allow us to distinguish
a polyclonal population with a mix of biallelic and monoallelic recombination
patterns from a monoclonal population with a predominance of one or the other
pattern.
To distinguish the recombination patterns in situ, we developed FISH probes
targeting the 64kb region of DNA between V29-1, the second-most 3’ variable region
of the TCR beta locus on chromosome 7, and D1, the most 5’ diversity region (69).
An additional, rarely used variable region, V30, is located 3’ of the C region (69).
Control probes were developed targeting the DNA regions immediately 5’ and 3’ of
the TCR beta locus, so as not to be involved in genetic recombination. As successful
V-DJ recombination involving any of the variable regions other than V30 causes the
excision and rapid destruction of the 64kb region of the TCR beta locus, DNA FISH
performed with probes for this test region should be able to distinguish a monoclonal
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population of T cells from a polyclonal population (70). Specifically, in a polyclonal
population, every cell should display the control probe signal on both alleles, but
there should be a mix of cells with one allele having only D-J recombination, and
therefore one test probe signal, and cells with both alleles having V-DJ
recombination, and no test probe signals. A monoclonal population should have one
type of cells or the other. In an actual tissue sample containing a monoclonal sample,
there are still always polyclonal T cells and non-lymphoid cells intermixed with
monoclonal T cells, and in this situation, there should be a preponderance of cells
with either one test probe signal or no test probe signal.
In situ clonality assays, for which random monoallelic gene expression and
genetic recombination within TCR genes represent two distinct and promising
approaches, have the potential to add to our understanding of carcinogenesis and
facilitate clinical diagnosis of malignancy. Random monoallelic gene expression, if it
turns out to be a successful target, could be used in a variety of tissue and tumor
types. Further research will continue to characterize the large variety of human
genes known to be subject to random monoallelic expression and the extent to which
this occurs in various tissue types. Genetic recombination within the T cell receptor
beta locus may be a technically easier assay, requiring DNA FISH alone without the
need for RNA FISH, but as described in this thesis, it is limited to the study of T cell
proliferations. Nevertheless, if the principle works for T cells, it should be possible to
develop an analogous test for B cells through analysis of recombination within the
immunoglobulin heavy chain locus.
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Statement of Purpose
The aim of this thesis is to describe and develop two methods of in situ analysis of the
clonality of populations of human cells, both of which rely upon fluorescence in situ
hybridization (FISH). In the first method, a combination of DNA FISH and RNA
FISH will be used to characterize the expression patterns in lymphoid tissues of two
genes which are known to be subject to random monoallelic gene expression. In the
second method, DNA FISH will be used to characterize the genetic recombination
patterns of the T cell receptor beta locus in T cells. Our hypothesis is that both of
these methods should be able to distinguish statistically a monoclonal population of
cells from a polyclonal population within tissue sections on a microscope slide.
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Methods
Probe Generation:
DAPK1 and EBF probes: DNA and RNA FISH probes were generated using an
adaptation of the method used by Gimelbrant et al., chosen because of their
successful use for both DNA and RNA FISH in that paper (50). BAC clones were
obtained from the BACPAC Resource Center, available at bacpac.chori.org,
containing between 200-400 kb of the two genes in question. The great majority of
DNA within these BACs consists of introns but some exon sequence is included. For
DAPK1, the clone RP11-107G16 was obtained, and for EBF, RP11-155P16. These
were the same BAC clones used by Gimelbrant et al. To amplify BAC DNA, the
clones in E. coli were incubated in LB media containing 12.5 (m)g/ml
chloramphenicol. DNA was isolated from 5ml bacterial cultures using the Qiagen
QiaPrep Spin Miniprep kit, eluated from the spin column with 50 (m)l of Qiagen
elution buffer (EB) in the final step.
For verification that the BAC DNA contained the appropriate genetic
sequences of DAPK1 or EBF, PCR was performed using primers chosen from the
NCBI sequences for both genes (www.ncbi.nlm.nih.gov/gene) using MacVector
software. For DAPK1, the primers chosen were TCTGTGTCCATCCCCCCGAT,
forward, and CCATCTATTCCCTTTCCTTTCCGT, reverse, both presented in 5’ to
3’ direction. These primers are complementary to DNA sequences approximately 3.5
kb apart, within an intron of DAPK1 according to the NCBI database, and were
chosen to be that far apart in case they might be used for generation of FISH probe
instead of BAC clone verification. For EBF, the primers chosen were

21
TTCTCTCTCTTGGCTAAGCGG, forward, and CAATGAGCGGAAAAGCGAGG,
reverse, also presented 5’ to 3’. These primers are complementary to DNA sequences
approximately 3.3 kb apart within an intron of EBF, according to the NCBI database.
Verification PCR was performed as follows: 17.3 µl H2O, 1 µl forward primer, 1 µl
reverse primer, 2 µl clone DNA or H20 for control, 0.5 µl Mg2+ 50x buffer, 0.5 µl
50x dNTP mix, 0.2 µl Taq polymerase, were mixed and subjected to 35 cycles of
PCR at a 64˚C annealing temperature. The PCR products were separated by 1%
agarose gel electrophoresis at 120 mV for 30 minutes, with the results shown in
Figure 1.

TCR beta probes: In a similar manner, BAC clones were selected containing regions
of the TCR beta (TCRB) locus. According to the NCBI sequence, there is a 64 kb
region between V29-1 and D1, as referred to above. Comparing the NCBI Clone
Registry and Map Viewer (available at
www.ncbi.nlm.nih.gov/projects/genome/clone/) with the sequence map of TCRB, the
BAC CTD-3217E23 was found to contain a 16kb region within the target 64 kb. This
BAC was acquired from Invitrogen (clones.invitrogen.com), and is abbreviated VDR,
for V-D region. The BAC RP11-368I15 was obtained from the BACPAC Resource
Center containing a 250 kb region 3’ to the TCRB locus for use as a control, here
abbreviated 3CR, for 3’ control region. This clone had been used by Soulier et al. in
an experiment using DNA FISH to identify the TCRB locus (71). An additional
BAC, RP11-10L5 acquired from the BACPAC Resource Center contains
approximately 250kb of DNA 5’ to the TCRB locus as an additional control, and is
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abbreviated 5CR, for 5’ control region. Each of these BAC clones in E. coli were
cultured in LB media containing 12.5 µg/ml chloramphenicol, and the DNA was
extracted from the bacteria using the Qiagen QiaPrep Spin Miniprep kit as above.
The clones were verified by PCR to contain the appropriate region of DNA, using the
same PCR parameters as for DAPK1 and EBF above. Primers were chosen using the
MacVector program from the NCBI genetic sequence of TCRB and the surrounding
DNA regions to be 150-350 bp apart, as follows, all listed 5’ to 3’:
VDR: CCACTAAATGATGTTGTC, forward;
TGTGCTCGTTAAGGATTTC, reverse.
3CR: TTTGGGGAGCACCCTTTG, forward;
CAGGAAGGACAGCTCCT, reverse
5CR: GTTAAAACTTACCTCATTAG, forward;
GTGTGGCAAACAGACAG, reverse
Gel electrophoresis separation of the PCR products for the TCRB probes with water
controls (PCR amplification performed without template added) is presented in
Figure 2.

In subsequent experiments conducted by Jonathan Murphy, an attempt was made to
increase the amount of signal obtained from the VDR region of the TCRB loci by
generating twenty-two non-overlapping probes from the VDR using PCR of VDR
DNA from whole cell DNA. These probes ranged in size from 2.8 kb to 3.5 kb in
length, and cumulatively covered approximately 55 kb of the 64 kb region between
V29-1 and D1. Together, these probes covered about 39 kb of DNA beyond that
within the CTD-3217E23 BAC. (BACs covering the entire 64 kb region are
available, but all of these contain considerable amounts of DNA outside the 64 kb
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region, rendering those BACs unsuitable for our purposes; i.e., all DNA
complementary to the probe is deleted as a result of V-DJ joining within the TCRB
locus.
Additionally, twenty-three probes, ranging in size from 3.0 kb to 3.6 kb in
length, were generated from the 3’ control region. The PCR to generate the probes
was performed as follows: 18 µl H2O, 0.25 µl forward primer, 0.25 µl reverse primer,
1.5 µl clone DNA, 2.0 µl Mg2+, 2.5 µl 10x buffer, 0.5 µl 50x dNTP mix, 0.2 µl Taq
polymerase, were mixed and subjected to 37 cycles of PCR at a 47.5˚C annealing
temperature. The PCR products were separated by 0.7% agarose gel electrophoresis
and purified from the gel using the Qiagen Gel Purification kit, eluting with 30 ul EB
buffer (Qiagen).

Probe Labeling:
Probes were labeled using the Vysis Nick Translation Labeling Kit (Vysis No.
32-801300, now Abbott 07J00-001) as follows: 17.5 µl Miniprep clone DNA were
mixed with 5 µl 0.1mM dTTP, 10 µl 0.1 mM dNTP, 5 µl 10x nick translation buffer,
10 µl nick translation enzyme, and 2.5 µl of dUTP tagged with either 0.2 mM
Spectrum Red (now Abbott No. 02N34-050) or 0.2 mM Spectrum Green (now Abbott
No. 02N32-050). The resulting mixture was vortexed, briefly centrifuged, and
incubated for fourteen hours at 15˚C, before the nick translation reaction was stopped
by heating the samples to 70˚C for ten minutes. At this point, 10 µl of Cot-1 DNA
(Abbott No. 06J31-001) and 150 µl 100% ethanol were added, the mixture was again
vortexed and briefly centrifuged before being placed at -80˚C for 30 minutes. The
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resulting sample was centrifuged at 4˚C at 12,000 rpm for 30 minutes, the supernatant
was discarded, and the pellet was resuspended in 20 µl hybridization buffer (500 µl
formamide, 100 µl 20xSSC, 200 µl dextran sulfate, 200 µl dH2O). The labeled
probes were stored at -20˚C until use.

Tissue Preparation:
Both polyclonal tissue and monoclonal cell lines were used as material for
FISH analysis with both sets of probes. Benign human tonsil and thymus tissue, fixed
in formalin and embedded in paraffin, were obtained from the Molecular Diagnostics
Service of the Yale Department of Pathology, where these tissues and cells are
frequently used as controls in their clinical assays. 10 µm-thick sections were cut
from the paraffin blocks and transferred to slides by the Yale Pathology Tissue
Services, Research Histology Service.
The clonal epithelial cell lines HESC (a human endometrial line) and HCT116
(a human colon cancer line) were obtained and cultured in DMEM and McCoy’s 5A
Modified Media, respectively, with 10% FBS, 1% penicillin/streptomycin, and 1%
glutarate added. These cell lines were grown directly on eight chambered slides,
which were then washed with PBS, fixed with a 1:1 methanol:acetone mixture for
five minutes, air-dried, and washed again in 2xSSC for sixty minutes before being
stored at 4˚C.
The T cell lines Jurkat, HSB, HSC, SKW3, SUPT1, HUT78, and HPB-ALL
were obtained by generous donation from the laboratory of Peter Cresswell. Ph.D.,
Yale University, Department of Immunobiology. The B cell line Raji was acquired
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from the laboratory of George Miller, M.D., Yale University, Department of
Pediatrics. These clonal lymphocyte lines were cultured in RPMI media with 10%
FBS, 1% pen/strep, 1% glutarate. Cell pellets for each cell line were created by
spinning 32 ml of each culture at 1500 rpm for three minutes, removing the
supernatant, resuspending in 10 ml PBS, vortexing, centrifuging again at 1500 rpm
for three minutes, removing the supernatant and resuspending in 10 ml of 10%
buffered formalin. After fixing for one hour in formalin, the cultures were
centrifuged again at 1500 rpm for three minutes, dehydrated with successive
resuspensions in 10 ml 70%, 95%, and 100% ethanol before finally being
resuspended in 40 µl Histogel (available at www.labstore.com, No. HG-4000). These
cell pellets were cut into 10 µm sections with a microtome and placed on slides by
Research Histology.
In the subsequent experiments conducted by Jonathan Murphy, the clonal B
cell line Namalwa and the clonal T cell line Jurkat were cultured in the same fashion
as the T cell lines above. 1 ml of the cell lines in RPMI media was centrifuged at 300
G for five minutes and the pellet was resuspended in 300 µl PBS. 200 µl of this
suspension was added to a single well of an eight-well poly-D-lysine coated slide.
The slide was centrifuged for five minutes at 200 G. The polystyrene vessel was
removed from the slide, and the slide was submerged in 0.075 M KCl hypotonic
solution for twelve minutes at 37˚C, followed by submersion in a 70% ethanol
solution for five minutes. The slide was allowed to air dry, and was stored at 4 ˚C
prior to use.
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Sequential RNA and DNA FISH:
Only DAPK1 and EBF probes were used for sequential RNA and DNA FISH, which
was carried out on tonsil, thymus, the Jurkat and HUT78 cell pellets, and the HESC
and HCT116 glass slides. All but the HESC and HCT116 glass slides required
deparaffinization prior to hybridization.

Deparaffinization: Slides requiring deparaffinization were heated at 56˚C for 2-3
hours, before being immersed in xylene three times for ten minutes each at room
temperature. Two final washes in 100% ethanol for five minutes at a time followed,
before the slides were allowed to air dry.

Probe Hybridization: Following deparaffinization, if necessary, slides were
pretreated in 2xSSC at 37˚C for one hour before immersion in 1:25 dilution of the
protease Digestall3 (Zymed, now Invitrogen) for five minutes at room temperature.
After protease digestion, slides were washed in PBS-T for two minutes, then fixed in
10% buffered formalin for one minute before a second wash in PBS-T for two
minutes, all at room temperature. Following this washing, slides underwent
sequential dehydration in 70%, 95%, and 100% ethanol for two minutes each at room
temperature, and were allowed to air dry. At this point, 10 µl of either DAPK1 or
EBF probe solution, having been denatured previously at 73˚C for five minutes, were
applied. A coverslip was sealed on with rubber cement, and the slides were placed on
a plate heater at 37˚C, where they incubated for fourteen hours to allow RNA
hybridization to occur. Following hybridization, the coverslips were removed, and
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the slides underwent stringency washing in 0.5xSSC at 72˚C two times for five
minutes each, followed by immersion in PBS-T for two minutes at room temperature.
They were again fixed in 10% buffered formalin for one minute before a wash in
PBS-T and sequential dehydration in 70%, 95%, and 100% ethanol for two minutes
each at room temperature. Following air-drying, another 10 µl of the same probe
solution, either EBF or DAPK1, was applied, this time labeled with the opposite
color, either Spectrum Red or Spectrum Green. A coverslip was sealed on with
rubber cement, and this time, the slides were incubated at the denaturation
temperature of 73˚C on a plate heater for five minutes before incubation for fourteen
hours at 37˚C to allow DNA hybridization to occur. A second stringency wash
followed, with 0.5xSSC at 72˚C two times for five minutes each, followed by
immersion in PBS-T for two minutes at room temperature. 15 µl of DAPI was added
to stain the nuclei, a coverslip was applied, and the slides were stored at 4˚C.
Microscopic examination was performed with an Olympus fluorescence microscope
having polarized filters able to detect Spectrum Red and Spectrum Green.

DNA FISH Alone:
For experiments requiring DNA FISH alone, we used the VP 2000 (Abbott
Molecular No. 02J11-060) slide processor utilized by the Molecular Diagnostics
Service for clinical FISH assays. This instrument is calibrated to process formalinfixed, paraffin-embedded tissue, so we were able to use slides prepared from tonsil,
thymus, and the T-cell and B-cell pellets. Both DAPK1 and EBF (as a control) and
the TCR beta probes were used. On the VP 2000 Processor, slides were incubated
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for sixty minutes at 55˚C, before immersion in xylene three times for ten minutes
each at room temperature, and in 100% ethanol two times for five minutes each, also
at room temperature. Slides then dried for five minutes at 55˚C, and were placed in a
0.2N HCl bath for fifteen minutes at room temperature. Next they were washed in a
water bath for three minutes at room temperature, before immersion in pretreatment
solution (VP 2000 reagent, Abbott Molecular 30-801250) for thirty minutes at 80˚C.
Following pretreatment, slides were immersed in protease solution (Abbott Molecular
30-801255, 0.1 N HCl) for thirty minutes at 37˚C. They were then washed in 2xSSC
for five minutes, and finally 70%, 85%, and 100% ethanol for one minute each, all at
room temperature. After drying for five minutes at 55˚C, 10 µl of either EBF or
DAPK1 probes, or a mixture of 7µl VDR probes with 7 µl of either 3CR or 5CR were
applied to a slide. A coverslip was placed on the slides, sealed with rubber cement,
and slides were placed on a plate heater at 73˚C for five minutes before incubating at
39˚C for sixteen hours. Following hybridization, the coverslips were removed and
the slides were placed in posthybridization buffer (67 ml 20xSSC, 547 ml ddH2O, 2
ml Igepal CA 630) for 120 minutes at 74˚C. At this point, 10 µl DAPI was added, a
coverslip was placed on the slides, and the slides were stored at 4˚C until microscopic
examination.
In the subsequent experiments conducted by Jonathan Murphy, the probes
generated by PCR were added to the 8-well slide containing clonal Namalwa or
Jurkat cells, following the VP2000 protocol as described above. Following
hybridization, the coverslips were removed and slides were placed in 0.4XSSC/0.3%
NP-40 for two minutes at 73˚C, followed by 2XSSC/0.1% NP-40 at room
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temperature for one minute. Slides were allowed to air dry for ten minutes at room
temperature, at which point 10 µl DAPI was added, a coverslip was applied, and the
slides were stored at 4˚C until microscopic examination.
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Results
We tested both methods designed to detect cell clonality in situ, the first to
assess allelic expression patterns of DAPK1 and EBF, both of which are known to be
subject to random monallelic gene expression, and the second to assess the status of
allelic recombination in the T cell receptor beta locus.
To test the first method, probes corresponding to introns of the DAPK1 and
EBF genes were hybridized to benign tonsil and thymus tissue as well as to clonal T
cell pellets and clonal epithelial cells. These experiments either involved sequential
RNA and DNA FISH with distinct probes labeled with different fluorophors to
distinguish DNA from RNA, or involved DNA FISH alone with a single fluorophor.
The DNA FISH served to identify the two alleles in each cell and provided a control
for accessibility of each allele for hybridization. RNA FISH allowed the
determination of whether a cell expressed DAPK1 or EBF at one or both alleles.
Only cells containing two distinct DNA FISH hybridization loci and at least one RNA
FISH hybridization locus could be used for clonal assessment. Cells not meeting
these criteria were disregarded.
Under the experimental conditions used, initial attempts at sequential RNA
and DNA FISH resulted in no cells that could be counted for clonal assessment. A
representative image is shown in Figure 3, which demonstrates DAPI signal
identifying lymphocyte nuclei, and no appreciable green signal identifying the
DAPK1-encoding DNA alleles or red signal identifying nascent RNA being
transcribed at one or both alleles.
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In view of these results, RNA FISH was set aside, and DNA FISH was
performed alone on tonsil tissue using the VP 2000 Processor, with green-labeled
probes to identify the DAPK1 or EBF alleles in separate hybridizations. These
hybridizations were more successful. Representative images are shown in Figures 4
and 5, which illustrate DNA FISH on tonsil tissue using DAPK1 and EBF probes,
respectively.
To test the second method, which involved analysis of recombination in the
TCR beta gene and required only DNA FISH without RNA FISH, probes
corresponding to the VDR region between V29-1 and D1 of the TCR beta locus along
with probes for control regions both 5’ and 3’ of the TCRB locus were hybridized to
tonsil, thymus, and monoclonal T-cell pellets using the VP 2000 Processor. The
VDR probes were labeled with either red or green fluorophor, using a different color
from the control region probes to distinguish the test signals from the control signals.
Only cells containing two control region signals identifying the TCR beta locus could
be used for clonal assessment. Successful analyses should reveal a VDR signal
present next to one or neither of the control region signals, depending on whether one
or both alleles had undergone complete V-DJ rearrangement and lost the region of
DNA to which the VDR probe should hybridize.
Under the experimental conditions used, no cells demonstrated VDR signal
next to a control region signal in a cell containing two control region signals. Very
few cells contained two control region signals, and the presence of nonspecific
background signal rendered most experiment iterations unusable despite stringency
washings. A representative image is shown in Figure 6, which is a composite of
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green, red, and blue filtered images of benign thymus tissue, to which red-labeled
VDR and green-labeled 3CR probes have been hybridized. While there are multiple
red signals, their size and distribution indicates that they most likely represent
nonspecific background signal instead of true VDR hybridization. As a comparison,
Figure 7 is a green-filtered image of thymus tissue to which green-labeled 3CR
probes have been hybridized. While there are certainly some larger signals that may
be non-specific, the presence of several smaller signals, often in pairs, suggests that at
least some of the green signals reflect true hybridization. To be sure of this, it would
be helpful to see at least some cells with red VDR signals, but under these
experimental conditions none were identified.
In a subsequent experiment, conducted by Jonathan Murphy, the second
method was again tested, this time using PCR-generated probes from the 64 kb test
region between V29-1 and D1 at the TCRB locus and from the 3CR control region.
The test region probes were labeled green, and the control region probes were labeled
red. These probes were hybridized to clonal Namalwa B cells and to clonal Jurkat T
cells. Figures 8 and 9 show Namalwa B cells photographed in the fluorescence
microscope using a red filter and a green filter, respectively. The red-filtered image
demonstrated two red signals in most of the Namalwa cells, most likely identifying
the control regions located just 3’ to the two alleles of the T-cell receptor beta locus.
The green-filtered image demonstrated two green signals in identical locations, with
occasional extraneous signals that most likely represent artifact. The green signals
that overlap with the red signals identified on the red filter most likely represent true
hybridization to the T cell receptor beta locus. The test region is intact at both alleles
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in these B cells, which have not undergone recombination within the TCRB loci. By
comparison, Figures 10 and 11 show Jurkat T cells photographed using a red filter
and a green filter, respectively. The red-filtered image again demonstrated two red
signals in most cells, likely identifying the control region 3’ to the TCRB locus, but
the green-filtered image demonstrates only one green signal that overlaps with the red
signals in each cell, along with occasional artifactual signals that do not overlap with
red signals. The presence of only one overlapping signal in these T-cells is consistent
with the fact that one of the TCRB alleles has successfully undergone VDJ
recombination, and the second allele has not undergone V-DJ joining. While these
images represent analyses of only two clonal cell lines, they suggest that the use of
DNA FISH to determine the status of T cell receptor beta recombination may, with
additional refinements, be used to assess clonality of T cells in situ.
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Discussion
In this thesis, two promising methods of detecting a monoclonal population of
human cells have been described, although their feasibility and usefulness cannot yet
be determined as the molecular techniques are still being refined. The promise of
both methods relies upon several necessary assumptions, which could not be affirmed
or rejected in this study. Unless these assumptions are rejected by subsequent work,
the clonality assays proposed here have the potential to become valuable clinical tools
to aid in the diagnosis of malignancy, or at the very least useful methods for studying
malignant transformation and preneoplastic lesions.
Potential pitfalls to the use of random monoallelic gene expression as an assay
for monoclonality would include the finding that this phenomenon occurs in too few
cells within a tissue, that the phenomenon is limited to only a small set of tissues, that
the progeny of a dividing cell do not retain the same pattern of allelic inactivation, or
that even a single cell can change its pattern of allelic inactivation during its lifetime.
While any of these pitfalls could turn out to be real, the experiments described in this
thesis did not fail because of any of them.
Similarly, using FISH to analyze T cell receptor gene rearrangement as an
assay for clonality of T cell populations would be problematic if the ratio of human T
cells with rearrangements of one TCR beta allele to those with rearrangements of
both is either too small or too large to allow statistically significant analysis of
variations within cell populations, or that a cell with only one allelic rearrangement
early in its development can frequently undergo a second rearrangement during its
later life. The experiments described in this thesis found no evidence to suggest that
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these problems applied, but neither did they rule out the possibility of these problems
potentially complicating the assay.
The inability of this experiment to support or reject the necessary assumptions
underlying both proposed methods relies solely on the failure of our experimental
technique. In further experiments, we will attempt to increase the sensitivity and
specificity of the hybridization assays by pursuing one or several of the following
methods. First, the use of BAC clones as sources of probe, while successful in the
Gimelbrant et al. study, may result in the labeling of too much bacterial DNA and not
enough target human DNA to cause enough specific hybridization versus nonspecific
binding of probe. Instead, we can either purify the BAC DNA away from bacterial
genomic DNA, subclone it, or use pooled, labeled PCR products as probes that
specifically target the test regions. The resulting reduction of background signal may
allow more successful visualization of true hybridization. As described in the Results
section, our initial experiments with pooled, labeled PCR products have already been
very promising. Additionally, the fluorophors we used may not be bright enough to
be visible when hybridized to such short DNA regions as the VDR probe, which is
only 16 kb long. Using so-called indirectly-labeled probes rather than probes directly
labeled with fluorescent tags would allow the use of signal amplification steps to
increase the signal of the shorter regions and allow better visualization under the
microscope. For example, biotin-conjugated nucleotides incorporated into the probes
can be detected by incubating the hybridized probe with FITC-avidin, followed by
biotinylated anti-avidin, and a final round of FITC-avidin (65). One or several of
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these methods may improve the assays so that we can assess clonality on a routine
basis.
One of the more immediate areas where either method of in situ clonality
analysis would be useful is for very small biopsy specimens in which there are few
cells available for analysis. As the use of minimally invasive biopsy techniques
become more prevalent and biopsy samples become smaller, the challenge of
diagnosis on low numbers of cells has grown. Additionally, some neoplastic
disorders contain very few neoplastic cells, the bulk of the mass in these tumors being
made up of tissue reacting to the presence of the neoplastic cells. Hodgkin’s disease
is an example of such a disorder, in that the neoplastic Reed-Sternberg cell usually
makes up less than one percent of the cells in the mass. Finally, certain cancers are
being identified at earlier and earlier stages, when the total number of malignant cells
may be quite low.
A disease that illustrates all of the above diagnostic problems and for which in
situ analysis of clonality would be very useful is the assessment and diagnosis of
cutaneous T-cell lymphoma (CTCL). CTCL is a relatively rare malignancy, with an
estimated annual incidence of 1:100,000; treatment options are limited and prognosis
is often poor, depending upon the particular type (72). The diagnosis is often
difficult, relying primarily on histologic and immunophenotypic features that can be
difficult to distinguish from reactive lymphocytic responses, such as chronic
dermatoses, which are quite common (12, 13). Because of the difficulty in making
the distinction between CTCL and chronic dermatoses, the actual number of skin
biopsy specimens for which CTCL enters the differential diagnoses is very high. As
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the amount of tissue available for examination is often very small, an in situ assay
that could distinguish a reactive process from a monoclonal proliferation would be
valuable to clinicians and researchers. To this end, in 2003 Magro et al. published
their work using in situ RT-PCR to examine the TCR beta rearrangement patterns,
with primers distinguishing the 25 possible V region recombinations (26). They
examined the tissue of 28 patients with cutaneous T-cell infiltrates including benign
lesions as well as CTCL, diagnosed by clinical, histologic, and immunophenotypic
analysis. Of the eight cases of primary CTCL lymphoma, seven were identified as
monoclonal by in situ RT-PCR, while the other case was found to be “biclonal.”
As discussed earlier, there are several limitations to the potential for clinical
adoption of in situ RT-PCR as currently performed-–limitations that a DNA FISHbased assay would overcome. The amount of tissue required for DNA FISH is much
less, and DNA FISH does not require sequential iterations to distinguish the 25
possible V-DJ rearrangements. However, the DNA FISH-based assay as we have
described it could not identify the particular VDJ rearrangement of a monoclonal
population, as the RT in situ PCR-based assay can. Nevertheless, this property is
probably not necessary for a useful assay of clonality in T cell disorders. This
opinion is based on the diagnostic utility of immunohistochemical detection of
restricted kappa versus lambda light chain immunoglobulin associated with
monoclonal B cell processes. Therefore, if our proposed assay for clonal TCR beta
gene rearrangements can be performed successfully, it could facilitate clinical
examination of cutaneous T cell proliferations with the possibility of emerging as an
important diagnostic assay. In the long run, if the in situ assay using random
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monoallelic gene expression can be perfected, this too would be applicable to
cutaneous T cell disorders.
We conclude that although limits of time prevented the full development of
the in situ assays to identify clonality proposed here, both have the potential to
become valuable tools in research and clinical practice. They certainly merit further
investigation.
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Figures:
Figure 1.

BAC Clone Verification: 2% agarose gel electrophoresis with PCR products of BAC
clone DNA using probes complementary to DAPK1 and EBF sequences. Lane 1, 1
kb ladder of size markers. Lanes 2-6, PCR products of DNA extracted from BAC
clone RP11-107G16 with primers targeting DAPK1 reveals ~3.5kb product, with a
water control in Lane 6. Lane 7, blank. Lanes 8-11, PCR products of DNA extracted
from BAC clone RP11-155P16 with primers targeting EBF reveals ~3.3kb product,
with a water control in Lane 11.
Figure 2.

BAC Clone Verification, cont’d: Composite 2% agarose gel electrophoresis of PCR
products of BAC clone DNA using probes complementary to VDR, 3CR, and 5CR
sequences. Lane 1, 100 bp ladder. Lane 2, blank. Lanes 3-6, PCR products of DNA
extracted from BAC clone CTD-3217E23 with primers targeting VDR reveals ~300
bp product, with a water control in Lane 3. Lanes 7-10, PCR products of DNA
extracted from BAC clone RP11-368I15 with primers targeting 3CR reveals ~250 bp
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product, with a water control in Lane 7. Lanes 11-14, PCR products of DNA
extracted from BAC clone RP11-10L5 with primers targeting 5CR reveals ~250 bp
product, with a water control in Lane 11.
Figure 3.

DAPK1 Sequential RNA and DNA FISH: Representative composite image of blue-,
red-, and green-filtered microscopy of a section from a monoclonal HSB T cell pellet
hybridized first to red-labeled DAPK1 probe in RNA FISH, followed by greenlabeled DAPK1 probe in DNA FISH. Nuclei have been stained blue with DAPI,
which binds to DNA and therefore marks the entire nucleus of interphase cells.
Neither red nor green signals are visible, suggesting that little, if any hybridization
had occurred. A significant amount of nonspecific and non-nuclear red and green
signal was present, not visible in this image. The only signals suggestive of true
hybridization occurred with DNA FISH using the VP 2000 processor, and not with
sequential RNA and DNA FISH (see below). (x600 magnification)
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Figure 4.

DAPK1 DNA FISH Control: Green-filter microscopy of benign tonsil tissue
hybridized to DAPK1 probes in DNA FISH using the VP 2000 processor. Multiple
cells display two green signals suggestive of bone fide hybridization, although
simultaneous RNA FISH would help to confirm this. The extent of hybridization is
better determined by direct inspection under the microscope, rather than in
photographs, because of the hybridization signals lying in several focal plains. (x600
magnification)
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Figure 5.

EBF DNA FISH Control: Green-filter microscopy of benign tonsil tissue hybridized
to EBF probes in DNA FISH using the VP 2000 processor. Again, multiple cells
display two green signals suggesting bona fide hybridization. (x600 magnification)
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Figure 6.

TCR Beta DNA FISH: Composite image of blue-, green-, and red-filtered microscopy
of benign thymus tissue hybridized to red-labeled VDR probes and green-labeled
3CR probes by DNA FISH on the VP 2000 processor. Multiple red signals are
present, but the lack of cells with two green (control) signals and the large size of
several of the red signals indicate that these signals are unlikely to represent true
hybridization.
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Figure 7.

3CR DNA FISH Control: By comparison, green-filtered microscopy of benign
thymus tissue hybridized to green-labeled 3CR probe in DNA FISH on the VP 2000
processor indicates smaller signals, often with two signals in a cell, more suggestive
of true hybridization than the red signals in Figure 6. However, most cells contain no
green signals or obviously nonspecific signal (large, bright spots).
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Figure 8.

B Cell TCR beta DNA FISH Control: Red-filter microscopy of clonal Namalwa B
cells hybridized to pooled PCR-generated probes targeting the 3CR region, in DNA
FISH performed with the VP 2000 processor. Multiple cells display two red signals
suggestive of bona fide hybridization. This experiment was conducted by Jonathan
Murphy.
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Figure 9.

B Cell TCR beta DNA FISH: Green-filtered photograph of the same microscopic
view as Figure 8. Green-labeled PCR-generated probes specific to the 64 kb VDR
test region deleted in successful V-DJ recombination have been hybridized to clonal
Namalwa B-cells in DNA FISH. Again, multiple cells display two green signals
suggestive of bona fide hybridization to the TCRB test region, with occasional
artifactual signals.
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Figure 10.

T Cell TCR beta DNA FISH Control: Red-filter microscopy of clonal Jurkat T cells
hybridized to pooled PCR-generated probes specific for the 3CR region, in DNA
FISH performed with the VP 2000 processor. Multiple cells display two red signals
likely indicating the control region adjacent to the TCRB locus. This experiment was
conducted by Jonathan Murphy.
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Figure 11.

T Cell TCR beta DNA FISH: Green-filtered photograph of same microscopic view as
in Figure 10. Green-labeled pooled PCR probes targeting the test region between
V29-1 and D1 have been hybridized to clonal Jurkat T-cells in DNA FISH performed
with the VP2000 processor. Most cells have a single green signal overlapping one of
the two red signals in Figure 10, suggestive of a single non-rearranged TCRB allele.
The other green signals most likely represent artifact.

